Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — April 2024

Genmab — April 2024

Planlagt Fastgjort Låst Flyttet Genmab
759 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #732

    Due to Epkinly's tremendous efficacy, analysts at SVB Securities think that the drug could reach peak annual sales of $3 billion in the U.S. https://www.nasdaq.com/articles/could-this-new-drug-be-a-blockbuster-for-these-2-pharma-collaborators

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #733

      Sydbank epcoritamab
      He estimates the new drug’s annual peak sales potential at USD 3.5bn.https://medwatch.com/News/Pharma___Biotech/article15855008.ece

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #734

        Drug: Epcoritamab
        Companies: AbbVie and Genmab
        Used for: Lymphoma
        Est. 2028 sales: $1.7 billion https://www.fiercepharma.com/marketing/top-10-most-anticipated-drug-launches-2023

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #735

          Jefferies analysts previously predicted Epkinly could reach about $2.75 billion in peak sales.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #736

            Take your pick 😉

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #737

              the strength of the competition will greatly affect epco sales, it will be a battle

              1 Reply Last reply
              0
              • L Offline
                L Offline
                lahn1
                wrote on sidst redigeret af
                #738

                wise guy 😉

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #739

                  jyskebank monthly
                  https://www.jyskebank.dk/wps/wcm/connect/jfo/eb0962c6-b617-408e-8245-d9efbb1679e3/Danske+Aktier+-+April+2024.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE.Z18_P20418S0N05640Q0MBPDFT1PE7-eb0962c6-b617-408e-8245-d9efbb1679e3-oYK6XHG

                  1 Reply Last reply
                  0
                  • royalR Offline
                    royalR Offline
                    royal
                    wrote on sidst redigeret af
                    #740

                    "Vi anbefaler, at investorerne stille og
                    roligt begynder at stige ombord på toget, inden det kører." Zzzzzzzzzzzzzzzzzzz

                    1 Reply Last reply
                    0
                    • royalR Offline
                      royalR Offline
                      royal
                      wrote on sidst redigeret af
                      #741

                      KYSO. att.: Helge: "Den tålmodige investor II" bør handle om Genmab investorere. 🙂

                      1 Reply Last reply
                      0
                      • W Offline
                        W Offline
                        w
                        wrote on sidst redigeret af
                        #742

                        jyske undrer sig også over fald ovenpå positive nyheder

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #743

                          Det skrev Jyske også for 3 mdr siden

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Raun
                            wrote on sidst redigeret af
                            #744

                            Hvor er det da ved at være pinligt for Jyske Bank.... - Hold nu op, hvor har de gentaget sig selv mange gange igennem de seneste måneder.... - De må have et ordentlig læs aktier de meget gerne vil af med 🙂

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              GeorgeBest
                              wrote on sidst redigeret af
                              #745

                              Thanks E L. Do you know how the forecasters see the market share split between epco versus glofi/monesu? 50/50?

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #746

                                no, i don't. would be fun indeed to look at these same analysts forecasts for that

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #747

                                  Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors https://investors.bio-techne.com/press-releases/detail/418/bio-techne-appoints-dr-judith-klimovsky-to-board-of -Bio-Techne is a leading supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #748

                                    the new Endometrial Cancer trial with GEN1046 will not continue; due to [Enrollment challenged by availability of other treatment options] https://classic.clinicaltrials.gov/ct2/history/NCT06046274?A=10&B=11&C=merged#StudyPageTop

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #749

                                      it seems no patients were recruited yet, so the costs should be limited

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #750

                                        New trial - Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy (HexaBody-OX40) https://clinicaltrials.gov/study/NCT06391775

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #751

                                          TECVAYLI available in Spain from may1 https://www.vademecum.es/noticia-240430-Disponible+en+Espa+ntilde+a+++9660+TECVAYLI+sup++reg+++sup+++teclistamab+++el+primer+anticuerpo+biespec+iacute+fico+anti++BCMA+sup++1++sup++autorizado+para+el+tratamiento+de+pacientes+triple+expuestos+con+mieloma+m+uacute+ltiple_90351

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper